Hrt Financial LP Theravance Biopharma, Inc. Transaction History

Hrt Financial LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$8.29 - $9.92 $182,670 - $218,587	22,035 Added 16.77%	153,424 $1.3 Million
Q1 2024 May 13, 2024	BUY	$8.22 - $11.59 $437,057 - $616,240	53,170 Added 67.98%	131,389 $1.18 Million
Q4 2023 Feb 09, 2024	SELL	$8.58 - $11.4 $529,205 - $703,140	-61,679 Reduced 44.09%	78,219 $879,000
Q3 2023 Nov 13, 2023	SELL	$8.38 - $10.44 $1.35 Million - $1.68 Million	-161,182 Reduced 53.53%	139,898 $1.21 Million
Q2 2023 Aug 11, 2023	BUY	$10.16 - $11.92 $3.06 Million - $3.59 Million	301,080 New	301,080 $3.12 Million
Q3 2022 Nov 14, 2022	BUY	$8.39 - $10.22 $283,917 - $345,844	33,840 Added 214.78%	49,596 $502,000
Q2 2022 Aug 12, 2022	SELL	$8.41 - $10.34 $164,272 - $201,971	-19,533 Reduced 55.35%	15,756 $142,000
Q1 2022 May 16, 2022	SELL	$8.33 - $12.96 $18,859 - $29,341	-2,264 Reduced 6.03%	35,289 $337,000
Q4 2021 Feb 14, 2022	BUY	$7.42 - $11.05 $278,643 - $414,960	37,553 New	37,553 $414,000
Q3 2021 Nov 15, 2021	SELL	$6.77 - $14.41 $109,335 - $232,721	-16,150 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$14.52 - $22.46 $91,766 - $141,947	6,320 Added 64.29%	16,150 $234,000
Q1 2021 May 17, 2021	BUY	$16.57 - $21.08 $162,883 - $207,216	9,830 New	9,830 $200,000
Q4 2020 Feb 16, 2021	SELL	$14.89 - $20.16 $313,925 - $425,033	-21,083 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$14.79 - $22.49 $61,452 - $93,445	4,155 Added 24.55%	21,083 $311,000
Q2 2020 Aug 14, 2020	BUY	$20.64 - $30.69 $349,393 - $519,520	16,928 New	16,928 $355,000

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.